Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Products
  • About us
  • News
  • Antimicrobial resistance
  • Aidian Academy
  • Customer stories
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Clean Card PRO
Read more
NEW! A comprehensive guide to monitoring surface hygiene now published
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Sustainability
  • Culture
  • Careers
  • Employee stories
  • Partnering and licensing
  • UN Global Compact Commitment | Aidian
  • News
  • Product news
  • AMR
  • Events
  • Stories from customers
  • COVID-19
  • About C-reactive protein (CRP)
  • AMR interview
  • CRP and lower respiratory tract infections
  • Educational materials
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Courses
  • Documents and materials
  • Frequently asked questions
  • Sleeping hygiene: monitoring cleanliness of pillows and bedding
Logo
Contact us Close
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Molecular diagnostics
      • SIBA
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagens
      • UniQ
    • Respiratory tract infections
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Sustainability
    • Culture
    • Careers
    • Employee stories
    • Partnering and licensing
    • UN Global Compact Commitment | Aidian
  • News
    • News
    • Product news
    • AMR
    • Events
    • Stories from customers
    • COVID-19
  • Antimicrobial resistance
    • About C-reactive protein (CRP)
    • AMR interview
    • CRP and lower respiratory tract infections
    • Educational materials
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Aidian Academy
    • Generally
    • Product information
    • Courses
    • Documents and materials
    • Frequently asked questions
  • Customer stories
    • Sleeping hygiene: monitoring cleanliness of pillows and bedding
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Are you prepared for tick season?

April 9, 2025 | News, Product news

  • View all
  • No results found
  • Loading...
News

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Back to all news
September 24, 2024
News,
AMR

Antibiotic resistant infections may cause 39 million deaths by 2050

The Lancet published recently a landmark study, which is the first comprehensive analysis of the global impact of antimicrobial resistance (AMR) from 1990 to 2021, with forecasts extending to 20501. This systematic analysis provides data and challenges posed by AMR across 204 countries.

Current situation with AMR

In 2021, AMR directly caused 1.14 million deaths and was associated with 4.71 million deaths globally. Between 1991-2021, resistance to Carbapenems in Gram-negative bacteria increased substantially. Also, deaths caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled. The study also reveals high variability in AMR burden between countries and age groups. A key finding was that deaths among children under five years old decreased by a remarkable 50% during this period, mainly due to effective global vaccination programs and improved hygiene, and access to clean water and sanitation. That was also an excellent reminder that infection prevention is highly effective in reducing antibiotic resistant infections. In contrast, deaths among those aged 25 years and older increased significantly, with an 80% rise in mortality among people aged 70 years and above.


Pills on a table

Future projections

The study evaluated that by 2050, AMR could be responsible for 8.22 million annual AMR -associated deaths and 1.91 million deaths directly attributable to AMR, if no significant changes are made. Cumulatively, AMR is projected to cause 39 million direct deaths to AMR and 169 million deaths attributable to AMR between 2025-2050. The regions expected to bear the highest burden are south Asia, southeast Asia, and east Asia, Oceania, and sub-Saharan Africa.

Because of the high variability of AMR burden by location and age, a multi-faceted approach is crucial. This includes strengthening infection prevention measures, promoting vaccination, reducing the over and misuse of antibiotics, and accelerating development of new antibiotics. These strategies aim to significantly reduce the projected number of AMR-related deaths by 2050. Existing infection prevention methods, including vaccination programs and investments in water, sanitation, and hygiene infrastructure, remain highly effective in lowering AMR burden.

QuikRead go CRP point-of-care tests contribute to the prevention of antibiotic resistance

Aidian's QuikRead go CRP products are valuable tools for guiding appropriate antibiotic prescribing and decreasing unnecessary antibiotic use. These CRP point-of-care tests contribute to the prevention on antibiotic-resistant infections and play a key role in enhancing Antimicrobial Stewardship in healthcare, ultimately helping to reduce antibiotic resistance2.

For more information about QuikRead go CRP products, visit the QuikRead go product page or contact us directly.


References

  1. Naghavi M et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet 2024; published online September 16. https://doi.org/10.1016/S0140-6736(24)01867-1
  2. Gentile I et al. The role of CRP POC testing in the fight against antibiotic overuse in European primary care: Recommendations from a European Expert Panel. Diagnostics 2023; 13:320. doi.org/10.3390/diagnostics13020320


Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B,
FI-02200 Espoo,
Finland

P.O. Box 83,
FI-02101 Espoo,
Finland

+358 10 309 3000
Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
Quick links
  • Aidian Academy
  • Aidian Connect
  • IFU Revision histories
Copyright © 2025 Aidian
  • Privacy Policy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy